Related Experiment Videos
Non-invasive vascular imaging: assessing tumour vascularity
1Department of Oncologic Diagnostics and Therapy, German Cancer Research Centre, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
European Radiology
|May 29, 1998
Summary
Non-invasive vascularity assessment using Doppler ultrasonography and contrast-enhanced MRI aids in characterizing tumors. Increased vascular permeability is a key indicator for differentiating malignant from benign tumors and monitoring therapy response.
Area of Science:
- Medical imaging
- Oncology
- Vascular biology
Background:
- Non-invasive assessment of tumor vascularity is crucial for diagnosis, prognosis, and therapy response.
- Tumor angiogenesis, the formation of new blood vessels, plays a key role in tumor biology.
- Current techniques like Doppler ultrasonography and contrast-enhanced MRI offer insights into tumor vascular features.
Purpose of the Study:
- To review the diagnostic approach of non-invasive vascularity assessment in characterizing tumors.
- To explore the role of tumor angiogenesis in tumor biology, prognosis, and therapy response.
- To discuss current and future instrumental developments in vascular imaging techniques.
Main Methods:
- Doppler ultrasonography for assessing vascular features and differentiation.
- Contrast-enhanced MRI (dynamic MRI with gadolinium chelates) for tumor detection and differentiation.
- Histological correlation to validate imaging findings, particularly capillary permeability.
Main Results:
- Doppler ultrasonography can aid in diagnostic differentiation, with high vascularity potentially indicating an aggressive disease course.
- Increased capillary permeability, observed in malignant tumors, is a significant criterion for differentiating them from benign processes.
- Permeability and perfusion factors appear more diagnostically valuable than overall vessel density.
Conclusions:
- Non-invasive vascularity assessment is a valuable diagnostic tool in oncology.
- Advanced imaging techniques and contrast agents are improving the estimation of intratumoral blood volume and vascular permeability.
- Future developments in Doppler and MRI promise enhanced capabilities for tumor characterization and therapy monitoring.